SynCardia Facebook SynCardia Twitter SynCardia LInkedIn SynCardia Google Plus SynCardia Youtube

SynCardia Systems, Inc.

Press Release:

CHRU Tours Performs 1st Implant of SynCardia’s Total Artificial Heart

Hospital is 30th in the World and 3rd in France to Become a SynCardia Certified Center

SynCardia's Total Artificial Heart SynCardia's Total Artificial Heart TUCSON, Ariz. – April 14, 2010 – On April 1, Centre Hospitalier Universitaire et Régional de Tours (CHRU Tours) in France, led by Prof. Michel R. Aupart, performed its first implant of the SynCardia temporary Total Artificial Heart into a 44-year-old male with ischemic heart disease who had suffered a heart attack that caused both sides of his heart to fail.

“This patient was in desperate need of the Total Artificial Heart to bridge him to a heart transplant,” said Prof. Aupart. “It was urgent for us to complete the three phases of certification training so that we could save his life by performing our first implant of the Total Artificial Heart.”

The surgery was proctored by Prof. Pascal Leprince, an experienced Total Artificial Heart surgeon from Groupe hospitalier de la Pitié-Salpétrière in Paris, which has performed over 200 implants of the Total Artificial Heart, more than any other hospital in the world.

CHRU Tours averages 800 cardiac surgeries annually (of which 200 are pediatric cases) and performed 23 heart transplants in 2009. Over 14 years, (1991-2005), CHRU Tours has achieved post-transplant survival rates of 91.3% at 1 year and 69.3% at 10 years.

CHRU Tours is the 30th hospital in the world and the third in France to become a SynCardia Certified Center.


About SynCardia Systems, LLC
SynCardia Systems, LLC in Tucson, Ariz., is the privately-held manufacturer of the world's first and only FDA, Health Canada and CE approved Total Artificial Heart. For people suffering from end-stage heart failure affecting both sides of the heart (biventricular failure), the SynCardia temporary Total Artificial Heart is used as a bridge to transplant, helping them survive until a matching donor heart becomes available. SynCardia also manufactures the Freedom® portable driver, which powers the temporary Total Artificial Heart and allows clinically stable patients to be discharged from the hospital to enjoy life at home while they wait for a heart transplant.

Follow SynCardia: Facebook | Twitter | LinkedIn | Google+

SynCardia Contact:
Janelle Drumwright,, (520) 547-7463

Search offcanvas